SCHEMBL24865656

SCHEMBL24865656

Cn1c(=O)n(C)c2cc(Nc3ccc(N4CCC(F)CC4)cc3)ccc21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.45
TP53 P04637 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 2/20 0.45
GAA P10253 2/20 0.44
PKM P14618 2/20 0.41
TRIM24 O15164 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
BCL6 P41182 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
XIAP P98170 1/20 0.40
BIRC2 Q13490 1/20 0.40
BRD1 O95696 2/20 0.39
BRPF1 P55201 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SYK P43405 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865209 0.90 SMN1; SMN2 (0.46) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL30336497 0.90 SMN1; SMN2 (0.46) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL24865299 0.88 BCL6 (0.50) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL31123270 0.88 BCL6 (0.50) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL24865788 0.88 SMN1; SMN2 (0.41) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL30336935 0.87 SMN1; SMN2 (0.49) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL24865236 0.87 SMN1; SMN2 (0.49) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL24865642 0.84 BCL6 (0.47) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL24865459 0.81 BCL6 (0.46) SMN1; SMN2TP53ALDH1A1HSD17B10GAA
SCHEMBL30885111 0.81 BCL6 (0.46) SMN1; SMN2TP53ALDH1A1HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 SMN1; SMN2 1657/4885TP53 1387/4885ALDH1A1 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.